Israel Englander Nymox Pharmaceutical Corp Transaction History

Millennium Management LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$0.33 - $0.5 $15,812 - $23,958	47,916 New	47,916 $16,000
Q3 2022 Nov 14, 2022	BUY	$0.22 - $0.61 $8,374 - $23,221	38,068 New	38,068 $16,000
Q1 2022 May 16, 2022	SELL	$1.21 - $2.0 $26,474 - $43,760	-21,880 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$0.95 - $2.1 $44,405 - $98,160	-46,743 Reduced 68.12%	21,880 $28,000
Q3 2021 Nov 15, 2021	SELL	$1.3 - $2.23 $331,163 - $568,072	-254,741 Reduced 78.78%	68,623 $141,000
Q2 2021 Aug 16, 2021	BUY	$1.46 - $2.48 $447,711 - $760,496	306,652 Added 1834.92%	323,364 $511,000
Q1 2021 May 17, 2021	BUY	$2.22 - $3.39 $37,100 - $56,653	16,712 New	16,712 $37,000
Q2 2020 Aug 14, 2020	SELL	$2.1 - $4.6 $816,177 - $1.79 Million	-388,656 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$1.69 - $3.88 $75,372 - $173,044	44,599 Added 12.96%	388,656 $909,000
Q4 2019 Feb 14, 2020	SELL	$1.73 - $2.42 $192,094 - $268,709	-111,037 Reduced 24.4%	344,057 $757,000
Q3 2019 Nov 14, 2019	SELL	$1.41 - $2.12 $986,523 - $1.48 Million	-699,662 Reduced 60.59%	455,094 $837,000
Q2 2019 Aug 15, 2019	BUY	$1.33 - $2.12 $511,515 - $815,347	384,598 Added 49.94%	1,154,756 $1.67 Million
Q2 2019 Aug 14, 2019	BUY	$1.33 - $2.12 $1.02 Million - $1.63 Million	770,158 New	770,158 $2.04 Million

150K

Ticker NYMX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 91,265,000
Market Cap $42.9M
Description
Nymox Pharmaceutical Corporation, a biopharmaceutical company, engages in the research and development of drugs for the aging population in Canada, the United States, Europe, and internationally. Its lead drug candidate is Fexapotide Triflutate (NX-1207), which has completed Phase III clinical trials for the treatment of benign prostatic hyperpl...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.